Absence of gp130 in dopamine β-hydroxylase-expressing neurons leads to autonomic imbalance and increased reperfusion arrhythmias

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 3, 2009, Pages

  Parrish, Diana C ^a   Alston, Eric N ^a   Rohrer, Hermann ^b   Hermes, Sam M ^a   Aicher, Sue A ^a   Nkadi, Paul ^c   Woodward, William R ^a,d   Stubbusch, Jutta ^b   Gardner, Ryan T ^a   Habecker, Beth A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b MAX PLANCK INSTITUTE FOR BRAIN RESEARCH   (Germany)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cardiac; Ischemia reperfusion; Parasympathetic; Sympathetic

Indexed keywords

ACTIN; BETA ADRENERGIC RECEPTOR; CYTOKINE; DOBUTAMINE; DOPAMINE BETA MONOOXYGENASE; GLYCOPROTEIN GP 130; NEUROPEPTIDE; NEUROTRANSMITTER; NORADRENALIN; TYRAMINE; TYROSINE 3 MONOOXYGENASE;

ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRAIN STEM; CATECHOLAMINERGIC SYSTEM; CELL SURVIVAL; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENOTYPE; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART INNERVATION; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART VENTRICLE PRESSURE; IMMUNOHISTOCHEMISTRY; INCIDENCE; INFLAMMATION; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; NORADRENALIN RELEASE; PARASYMPATHETIC GANGLION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION; SYMPATHETIC GANGLION; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE CELL; SYSTOLIC BLOOD PRESSURE; WILD TYPE;

ANIMALS; ARRHYTHMIAS, CARDIAC; BRAIN STEM; CYTOKINE RECEPTOR GP130; DOPAMINE BETA-HYDROXYLASE; GENOTYPE; HEART; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL REPERFUSION INJURY; NEURONS; NOREPINEPHRINE; PARASYMPATHETIC NERVOUS SYSTEM; SYMPATHETIC NERVOUS SYSTEM; TRANSGENES; TYROSINE 3-MONOOXYGENASE;

EID: 69249112289     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00409.2009     Document Type: Article

References (44)

1. Aoyama T, Takimoto Y, Pennica D, Inoue R, Shinoda E, Hattori R, Yui Y, Sasayama S. Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat. J Mol Cell Cardiol 32: 1821-1830, 2000.
2. 2-adrenergic stimulation in animals susceptible to sudden death. Circulation 96: 1914-1922, 1997.
3. Brar BK, Stephanou A, Liao Z, O'Leary RM, Pennica D, Yellon DM, Latchman DS. Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation. Cardiovasc Res 51: 265-274, 2001.
4. Cheng JG, Pennica D, Patterson PH. Cardiotrophin-1 induces the same neuropeptides in sympathetic neurons as do neuropoietic cytokines. J Neurochem 69: 2278-2284, 1997.
5. Dampney RA, Coleman MJ, Fontes MA, Hirooka Y, Horiuchi J, Li YW, Polson JW, Potts PD, Tagawa T. Central mechanisms underlying short- and long-term regulation of the cardiovascular system. Clin Exp Pharmacol Physiol 29: 261-268, 2002.
6. Du XJ, Cox HS, Dart AM, Esler MD. Sympathetic activation triggers ventricular arrhythmias in rat heart with chronic infarction and failure. Cardiovasc Res 43: 919-929, 1999.
7. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 53: 31-47, 2002.
8. Gritman K, Van Winkle DM, Lorentz CU, Pennica D, Habecker BA. The lack of cardiotrophin-1 alters expression of interleukin-6 and leukemia inhibitory factor mRNA but does not impair cardiac injury response. Cytokine 36: 9-16, 2006.
9. Guyenet PG. Central noradrenergic neurons: the autonomic connection. Prog Brain Res 88: 365-380, 1991.
10. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 7: 335-346, 2006.
11. Gwechenberger M, Mendoza LH, Youker KA, Frangogiannis NG, Smith CW, Michael LH, Entman ML. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 99: 546-551, 1999.
12. Habecker BA, Sachs HH, Rohrer H, Zigmond RE. The dependence on gp130 cytokines of axotomy induced neuropeptide expression in adult sympathetic neurons. Dev Neurobiol 69: 392-400, 2009.
13. Haverkamp W, Hindricks G, Gulker H. Antiarrhythmic properties of beta-blockers. J Cardiovasc Pharmacol 16, Suppl 5: S29-S32, 1990.
14. Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334: 297-314, 1998.
15. Hirota H, Chen J, Betz UA, Rajewsky K, Gu Y, Ross J Jr, Muller W, Chien KR. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97: 189-198, 1999.
16. Hoard JL, Hoover DB, Mabe AM, Blakely RD, Feng N, Paolocci N. Cholinergic neurons of mouse intrinsic cardiac ganglia contain noradrenergic enzymes, norepinephrine transporters, and the neurotrophin receptors tropomyosin-related kinase A and p75. Neuroscience 156: 129-142, 2008.
17. Ieda M, Kanazawa H, Kimura K, Hattori F, Ieda Y, Taniguchi M, Lee JK, Matsumura K, Tomita Y, Miyoshi S, Shimoda K, Makino S, Sano M, Kodama I, Ogawa S, Fukuda K. Sema3a maintains normal heart rhythm through sympathetic innervation patterning. Nat Med 13: 604-612, 2007.
18. Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetiere P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 352: 1951-1958, 2005.
19. Kreusser MM, Buss SJ, Krebs J, Kinscherf R, Metz J, Katus HA, Haass M, Backs J. Differential expression of cardiac neurotrophic factors and sympathetic nerve ending abnormalities within the failing heart. J Mol Cell Cardiol 44: 380-387, 2008.
20. La Rovere MT, Bersano C, Gnemmi M, Specchia G, Schwartz PJ. Exercise-induced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction. Circulation 106: 945-949, 2002.
21. Landis SC, Jackson PC, Fredieu JR, Thibault J. Catecholaminergic properties of cholinergic neurons and synapses in adult rat ciliary ganglion. J Neurosci 7: 3574-3587, 1987.
22. Levy MN, Blattberg B. Effect of vagal stimulation on the overflow of norepinephrine into the coronary sinus during cardiac sympathetic nerve stimulation in the dog. Circ Res 38: 81-84, 1976.
23. Lewis SE, Rao MS, Symes AJ, Dauer WT, Fink JS, Landis SC, Hyman SE. Coordinate regulation of choline acetyltransferase, tyrosine hydroxylase, and neuropeptide mRNAs by ciliary neurotrophic factor and leukemia inhibitory factor in cultured sympathetic neurons. J Neurochem 63: 429-438, 1994.
24. Li W, Knowlton D, Van Winkle DM, Habecker BA. Infarction alters both the distribution and noradrenergic properties of cardiac sympathetic neurons. Am J Physiol Heart Circ Physiol 286: H2229-H2236, 2004.
25. Li W, Knowlton D, Woodward WR, Habecker BA. Regulation of noradrenergic function by inflammatory cytokines and depolarization. J Neurochem 86: 774-783, 2003.
26. Loewy AD, Spyer KM. Central Regulation of Autonomic Function. Oxford: Oxford Univ. Press, 1990.
27. Lopez-Sendon J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J 25: 1341-1362, 2004.
28. Rao MS, Sun Y, Escary JL, Perreau J, Tresser S, Patterson PH, Zigmond RE, Brulet P, Landis SC. Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons. Neuron 11: 1175-1185, 1993.
29. Reis DJ, Granata AR, Joh TH, Ross CA, Ruggiero DA, Park DH. Brain stem catecholamine mechanisms in tonic and reflex control of blood pressure. Hypertension 6: II7-II15, 1984.
30. Saadat S, Sendtner M, Rohrer H. Ciliary neurotrophic factor induces cholinergic differentiation of rat sympathetic neurons in culture. J Cell Biol 108: 1807-1816, 1989.
31. Sheng Z, Pennica D, Wood WI, Chien KR. Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. Development 122: 419-428, 1996.
32. Smith LL, Kukielka M, Billman GE. Heart rate recovery after exercise: a predictor of ventricular fibrillation susceptibility after myocardial infarction. Am J Physiol Heart Circ Physiol 288: H1763-H1769, 2005.
33. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21: 70-71, 1999.
34. Stanke M, Duong CV, Pape M, Geissen M, Burbach G, Deller T, Gascan H, Otto C, Parlato R, Schutz G, Rohrer H. Target-dependent specification of the neurotransmitter phenotype: cholinergic differentiation of sympathetic neurons is mediated in vivo by gp 130 signaling. Development 133: 141-150, 2006.
35. Taga T. gp130, a shared signal transducing receptor component for hematopoietic and neuropoietic cytokines. J Neurochem 67: 1-10, 1996.
36. Tsuji H, Larson MG, Venditti FJ Jr, Manders ES, Evans JC, Feldman CL, Levy D. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 94: 2850 -2855, 1996.
37. Turnley AM, Bartlett PF. Cytokines that signal through the leukemia inhibitory factor receptor-beta complex in the nervous system. J Neurochem 74: 889-899, 2000.
38. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DW, Higgins AJ, Julian DG, Lab MJ, Manning AS, Northover BJ, Parratt JR, Riemersma RA, Riva E, Russell DC, Sheridan DJ, Winslow E, Woodward B. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 22: 447-455, 1988.
39. Wetzel GT, Brown JH. Presynaptic modulation of acetylcholine release from cardiac parasympathetic neurons. Am J Physiol Heart Circ Physiol 248: H33-H39, 1985.
40. Wollert KC, Chien KR. Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development. J Mol Med 75: 492-501, 1997.
41. Yamaguchi N, de Champlain J, Nadeau RA. Regulation of norepinephrine release from cardiac sympathetic fibers in the dog by presynaptic alpha- and beta-receptors. Circ Res 41: 108-117, 1977.
42. Yamamori T, Fukada K, Aebersold R, Korsching S, Fann MJ, Patterson PH. The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science 246: 1412-1416, 1989. [Erratum. Science 247(4940): 271, 1990.]
43. Yoshida K, Taga T, Saito M, Suematsu S, Kumanogoh A, Tanaka T, Fujiwara H, Hirata M, Yamagami T, Nakahata T, Hirabayashi T, Yoneda Y, Tanaka K, Wang WZ, Mori C, Shiota K, Yoshida N, Kishimoto T. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci USA 93: 407-411, 1996.
44. Zou Y, Takano H, Mizukami M, Akazawa H, Qin Y, Toko H, Sakamoto M, Minamino T, Nagai T, Komuro I. Leukemia inhibitory factor enhances survival of cardiomyocytes and induces regeneration of myocardium after myocardial infarction. Circulation 108: 748-753, 2003.